SHELIA REAGAN: Open Payments
NPI 1528517794 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,053 in 150 payments from 28 companies in 2025. Trend: 2023 $3,698 · 2024 $4,294 · 2025 $3,053
Food & beverage: $3,053
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 10 | $500 |
| Dexcom, Inc. | 23 | $295 |
| Novo Nordisk Inc | 15 | $259 |
| CeQur Corporation | 1 | $246 |
| Corcept Therapeutics | 13 | $215 |
| RECORDATI_RARE_DISEASES_INC. | 10 | $176 |
| Amgen Inc. | 18 | $173 |
| Ascendis Pharma Endocrinology Inc | 8 | $170 |
| OPKO Pharmaceuticals, LLC | 9 | $148 |
| Mannkind Corporation | 7 | $106 |
Products named: Omnipod, Dexcom G6 Transmitter, CeQur Simplicity, Korlym, Ozempic, ISTURISA, Yorvipath, RAYALDEE.
Industry payments across TX — which companies pay providers there.
